Ependymal tumor of brain

Summary

Ependymal tumor of brain (MONDO:0004245) is a cancer (an umbrella term covering 6 Mondo subtypes). A subtype of ependymal tumor — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Classification: Cancer
• Umbrella term: 6 Mondo subtypes

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	ependymal tumor of brain
Mondo ID	MONDO:0004245
DOID	DOID:7497
NCIT	C3861
SNOMED CT	254939008
UMLS	C0238029
MedGen	116038
GARD	0023897
Anatomy (UBERON)	UBERON:0000955
Is cancer (heuristic)	yes

Also known as: brain ependymal tumor · brain ependymal tumour · ependymal tumor of brain

Disease family

This is a subtype of ependymal tumor. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › nervous system neoplasm › neuroepithelial neoplasm › glioma › ependymal tumor › ependymal tumor of brain

Related subtypes (5): ependymoma, myxopapillary ependymoma, anaplastic ependymoma, ependymal tumor of spinal cord, RELA fusion-positive ependymoma

Subtypes (6): parietal lobe ependymal tumor, brain stem ependymoma, adult brain ependymoma, infratentorial ependymal tumor, supratentorial ependymal tumor, frontal lobe ependymal tumor

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.